TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers October 4, 1996